Fulcrum Therapeutics Inc (FULC)
7.71
+0.07
(+0.92%)
USD |
NASDAQ |
May 22, 16:00
7.71
0.00 (0.00%)
After-Hours: 20:00
Fulcrum Therapeutics Cash from Operations (Quarterly): -25.28M for March 31, 2024
Cash from Operations (Quarterly) Chart
Historical Cash from Operations (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | -25.28M |
| December 31, 2023 | -23.16M |
| September 30, 2023 | -22.91M |
| June 30, 2023 | -20.78M |
| March 31, 2023 | -24.12M |
| December 31, 2022 | -19.70M |
| September 30, 2022 | -27.88M |
| June 30, 2022 | -27.37M |
| March 31, 2022 | -22.11M |
| December 31, 2021 | -21.86M |
| September 30, 2021 | -22.57M |
| June 30, 2021 | -17.82M |
| March 31, 2021 | -16.23M |
| Date | Value |
|---|---|
| December 31, 2020 | -19.83M |
| September 30, 2020 | -4.504M |
| June 30, 2020 | -14.12M |
| March 31, 2020 | -15.20M |
| December 31, 2019 | -4.495M |
| September 30, 2019 | -13.02M |
| June 30, 2019 | -12.07M |
| March 31, 2019 | -9.897M |
| December 31, 2018 | -6.403M |
| September 30, 2018 | -4.12M |
| June 30, 2018 | -5.407M |
| March 31, 2018 | -6.632M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (Quarterly) Range, Past 5 Years
-27.88M
Minimum
Sep 2022
-4.495M
Maximum
Dec 2019
-18.75M
Average
-20.31M
Median
Cash from Operations (Quarterly) Benchmarks
| Bristol-Myers Squibb Co | 2.834B |
| Moderna Inc | -989.00M |
| Pfizer Inc | 1.09B |
| NovaBay Pharmaceuticals Inc | -1.572M |
| Palatin Technologies Inc | -8.607M |
Cash from Operations (Quarterly) Related Metrics
| Cash from Investing (Quarterly) | 38.13M |
| Cash from Financing (Quarterly) | 1.651M |
| Free Cash Flow | -92.50M |
| Free Cash Flow Per Share (Quarterly) | -0.4084 |
| Free Cash Flow Yield | -19.39% |